Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
- PMID: 11744618
- DOI: 10.1096/fj.01-0332fje
Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
Abstract
Vascular endothelial growth factor (VEGF) is a strong angiogenic mitogen and plays important roles in angiogenesis under various pathophysiological conditions. The in vivo angiogenic activity of secreted VEGF may be regulated by extracellular inhibitors, because it is also produced in avascular tissues such as the cartilage. To seek the binding inhibitors against VEGF, we screened the chondrocyte cDNA library by a yeast two-hybrid system by using VEGF165 as bait and identified connective tissue growth factor (CTGF) as a candidate. The complex formation of VEGF165 with CTGF was first established by immunoprecipitation from the cells overexpressing both binding partners. A competitive affinity-binding assay also demonstrated that CTGF binds specifically to VEGF165 with two classes of binding sites (Kd = 26 +/- 11 nM and 125 +/- 38 nM). Binding assay using deletion mutants of CTGF indicated that the thrombospondin type-1 repeat (TSP-1) domain of CTGF binds to the exon 7-coded region of VEGF165 and that the COOH-terminal domain preserves the affinity to both VEGF165 and VEGF121. The interaction of VEGF165 with CTGF inhibited the binding of VEGF165 to the endothelial cells and the immobilized KDR/IgG Fc; that is, a recombinant protein for VEGF165 receptor. By in vitro tube formation assay of endothelial cells, full-length CTGF and the deletion mutant possessing the TSP-1 domain inhibited VEGF165-induced angiogenesis significantly in the complex form. This antiangiogenic activity of CTGF was demonstrated further by in vivo angiogenesis assay by using Matrigel injection model in mice. These data demonstrate for the first time that VEGF165 binds to CTGF through a protein-to-protein interaction and suggest that the angiogenic activity of VEGF165 is regulated negatively by CTGF in the extracellular environment.
Similar articles
-
Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.J Biol Chem. 2002 Sep 27;277(39):36288-95. doi: 10.1074/jbc.M201674200. Epub 2002 Jul 11. J Biol Chem. 2002. PMID: 12114504
-
Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line.Cancer Lett. 2001 Dec 10;174(1):57-64. doi: 10.1016/s0304-3835(01)00683-8. Cancer Lett. 2001. PMID: 11675152
-
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.J Biol Chem. 1995 Jun 23;270(25):15059-65. doi: 10.1074/jbc.270.25.15059. J Biol Chem. 1995. PMID: 7797488
-
The biology of VEGF and its receptors.Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review.
-
Dissection of monocyte and endothelial activities by using VEGF-receptor specific ligands.Adv Exp Med Biol. 2003;522:75-82. doi: 10.1007/978-1-4615-0169-5_8. Adv Exp Med Biol. 2003. PMID: 12674212 Review. No abstract available.
Cited by
-
Connective Tissue Growth Factor: Regulation, Diseases, and Drug Discovery.Int J Mol Sci. 2024 Apr 25;25(9):4692. doi: 10.3390/ijms25094692. Int J Mol Sci. 2024. PMID: 38731911 Free PMC article. Review.
-
A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer's disease.Nat Commun. 2024 Mar 12;15(1):2243. doi: 10.1038/s41467-024-46630-z. Nat Commun. 2024. PMID: 38472200 Free PMC article.
-
Immunomodulatory roles of metalloproteinases in rheumatoid arthritis.Front Pharmacol. 2023 Nov 15;14:1285455. doi: 10.3389/fphar.2023.1285455. eCollection 2023. Front Pharmacol. 2023. PMID: 38035026 Free PMC article. Review.
-
Structural insights into regulation of CCN protein activities and functions.J Cell Commun Signal. 2023 Jun;17(2):371-390. doi: 10.1007/s12079-023-00768-5. Epub 2023 May 28. J Cell Commun Signal. 2023. PMID: 37245184 Free PMC article. Review.
-
CCN2 deficiency in smooth muscle cells triggers cell reprogramming and aggravates aneurysm development.JCI Insight. 2023 Jan 10;8(1):e162987. doi: 10.1172/jci.insight.162987. JCI Insight. 2023. PMID: 36625347 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous